Legend Biotech Corporatio...

NASDAQ: LEGN · Real-Time Price · USD
37.47
-0.24 (-0.64%)
At close: Aug 15, 2025, 3:59 PM
37.50
0.09%
After-hours: Aug 15, 2025, 06:06 PM EDT

Legend Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-305.33M -197.7M -158.36M -343.69M -285.3M -465.94M -518.12M -509.03M -531.34M -516.61M -445.72M -398.33M -438.92M -346.4M -386.21M -355.63M -297.29M -340.58M
Depreciation & Amortization
23.34M 22.84M 23.36M 21.91M 21.61M 25.23M 24.69M 24.59M 24.53M 19.65M 18.39M 16.85M 15.24M 14.49M 14.24M 12.29M 11.66M 11.42M
Stock-Based Compensation
44.45M 66.18M 68.94M 68.14M 65.41M 59.31M 47.68M 44.06M 41.93M 35.73M 34.34M 30.57M 27.25M 25.83M 22.48M 20.34M 14.45M 6.78M
Other Working Capital
-206.89M -185.42M -90.88M 74.36M 76.65M 51.82M 53.07M 27.44M 68.59M 134.88M 118.75M 146.44M 133.33M 119.61M 118.91M 53.51M 41.21M 23.57M
Other Non-Cash Items
174.35M 6.86M -148.6M 83.67M 28.93M 163.01M 241.57M 71.55M 87.58M -21.14M -24.61M -5.39M -8.73M 20.09M 106.76M 89.77M 92.64M 136.59M
Deferred Income Tax
n/a n/a n/a -124.37M -125.61M -125.61M -125.61M 11.69M -47.85M 30.01M 30.01M -29.82M 68.97M -8.89M -8.89M 38.01M n/a n/a
Change in Working Capital
-211.8M -161.49M 6.15M 74.66M 90.25M 60.86M -65.02M 5.82M 62.58M 169.13M 186.32M 165.04M 142.63M 141.77M 202.65M 115.55M 89.23M 11.17M
Operating Cash Flow
-274.98M -263.31M -143.37M -154.53M -139.56M -233.63M -390.87M -347.37M -358.64M -263.65M -201.28M -221.09M -193.57M -250.37M -198.47M -184.87M -204.65M -204M
Capital Expenditures
-22.05M -9.86M -30.65M -53.68M -57.09M -64.04M -45.52M -27.63M -23.82M -14.02M -22.27M -17.9M -28.85M -30.71M -35.36M -44.65M -39.13M -47.54M
Cash Acquisitions
n/a n/a n/a n/a -96K -96K -96K -1.06M -61K 820K 233.32M 234.64M 234.86M 234M 1.5M 1.15M 20K n/a
Purchase of Investments
-4.53B -1.94B -2.71B -4.31B -6.78B -5.3B -4.44B -2.65B -189.36M -349.36M -654.97M -560.37M -613.43M -453.43M -193.46M -163.07M -50M -50M
Sales Maturities Of Investments
4.92B 1.81B 1.93B 4.04B 5.98B 5.18B 4.73B 2.55B 405.53M 575.83M 614.86M 581.03M 410.39M 240.08M 200.08M 70M 50M 50M
Other Investing Acitivies
-36.01M -53.16M -54.35M -48.2M -58.97M -155.03M -120.56M -126.96M -102.77M 2.4M -248.03M -242.91M -242.04M -402.67M -187.32M -125.78M -183.28M -23.82M
Investing Cash Flow
332.57M -197.76M -851.21M -358.26M -896.41M -324.36M 90.38M -289.79M 47.17M 173.34M -77.09M -5.51M -239.07M -410.33M -194.98M -230.33M -183.28M -23.82M
Debt Repayment
-2.88M -4.04M -4.02M -2.78M -3.33M -2.17M -2.23M -3.94M -2.92M -2.98M -2.6M -1.61M -1.35M -1.3M -1.04M -1.42M -974K -974K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.27M 2.12M 3.7M 4.33M 7.01M 794.94M 793.72M 793.72M 791.83M 2.84M 2.93M 2.85M 3.65M 304.34M 304.26M 305.18M 313.26M 471.31M
Financial Cash Flow
3.59M 5.53M 5.7M 6.96M 3.67M 792.61M 791.49M 789.78M 1.17B 377.67M 377.98M 702.32M 325.74M 626.48M 626.66M 303.76M 312.28M 470.33M
Net Cash Flow
65.33M -455.87M -990.96M -504.19M -1.03B 237.52M 491.68M 150.74M 853.44M 282.26M 97.09M 474.4M -108.44M -34.51M 233.25M -111.05M -74.18M 243.5M
Free Cash Flow
-297.03M -273.17M -174.02M -208.21M -196.65M -297.67M -436.39M -375M -382.46M -277.67M -223.56M -238.99M -222.42M -281.08M -233.83M -229.51M -243.78M -251.54M